Meet us at ISN-WCN 2024 in Buenos Aires, 13–16 April!
TauroLock™ solutions meet the needs of patients suffering from kidney failure.
TauroLock™ solutions protect patients with central-venous catheters during cancer treatments.
TauroLock™ solutions facilitate parenteral nutrition for patients at all ages.
TauroLock™ is suitable for instillation in all central-venous access systems. It prevents the formation of bacterial biofilms and improves the patency rate.
TauroLock™-HEP100 can be used for patients who previously relied on heparin-based lock solutions. Central-venous catheters remain infection-free and sustain a high patency rate.
TauroLock™-HEP500 meets the particular needs of dialysis patients. It ensures a good flow-rate and prevents catheter-related infections as well as occlusions.
TauroLock™-U25.000 provides a strong protection against catheter-related complications. It contains taurolidine, 4 % citrate, and 25,000 IU of urokinase.
NutriLock™ is a heparin- and citrate-free lock solution. Based on the antimicrobial agent taurolidine, it protects patients against catheter-related infections.
Log in or sign up to download all available materials for free
Download a selected range of materials for free
Download materials on lock solutions in dialysis
Download materials on lock solutions in oncology
Download materials on lock solutions in parenteral nutrition
Download materials on our product range
Instructions for use of TauroLock™
Instructions for use of TauroLock™-HEP500
Instructions for use of TauroLock™-U25.000
Instillation protocol for TauroLock™ in dialysis
Instillation protocol for TauroLock™-HEP500 in dialysis
Instillation protocol for TauroLock™-U25.000 in dialysis
TauroLock™ brochure (full product range)
TauroLock™ 2+1 protocol, 2x weekly TauroLock™-HEP500, 1x weekly TauroLock™-U25.000
"Taurolidine-Citrate-Heparin – the superior lock solution"
"Taurolock™-HEP500 in dialysis – the best solution down the line"
"TauroLock™-HEP500 in dialysis, superior dialysis quality and protection from infection and inflammation"
Australian guidelines for haemodialysis catheters
DGfN recommendations for TauroLock™, TauroLock™-HEP500 & TauroLock™-U25.000 in dialysis
Dialysis standard of the German Society of Nephrology (DGfN)
Guideline for applied hygiene in dialysis (DGFaHD)
Spanish Clinical Guidelines on Vascular Access for Haemodialysis
Brazilian guidelines of the ANVS
Instructions for use of TauroLock™-HEP100
Instillation protocol for TauroLock™ in oncology
Instillation protocol for TauroLock™-HEP100 in oncology
Instillation protocol for TauroLock™-U25.000 in oncology
TauroLock™ in parenteral nutrition and chemotherapy
Guidelines of the Italian Association of Pediatric Hematology and Oncology (AIEOP)
Evidence-based recommendations for the use of permanent CVADs in paediatric oncology
TaurolockHep100® prophylactic lock for central venous access devices
Instructions for use of NutriLock™
Instillation protocol for NutriLock™ in parenteral nutrition
Instillation protocol for TauroLock™ in parenteral nutrition
Instillation protocol for TauroLock™-HEP100 in parenteral nutrition
Instillation protocol for TauroLock™-U25.000 in parenteral nutrition
TauroLock™ in parenteral nutrition
ESPEN guideline on home parenteral nutrition
ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Venous access
Prevention of infections related to central venous catheters (SFNCM)
Guideline of the German Society of Nutritional Medicine (DGEM)
TauroLock™ instillation protocol
TauroLock™-HEP100 instillation protocol
TauroLock™-HEP500 instillation protocol
TauroLock™-U25.000 instillation protocol
NutriLock™ instillation protocol
We'll keep you posted on upcoming events, free download materials, and research insights.